OnKure Therapeutics

Street sign indicating a lane merge

Biotech

OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot

OnKure is challenging the likes of Lilly, Relay and Scorpion in the PI3Kα blocker battle.

Max Bayer May 13, 2024 10:36am

handshake

OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial

Oct 14, 2021 8:15am